A study on patients of shock due to infection and observing blood test value in predicting their outcome.
- Conditions
- Health Condition 1: A419- Sepsis, unspecified organism
- Registration Number
- CTRI/2022/12/048102
- Lead Sponsor
- Fortis Escorts Heart Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients >= 18 years of age.
2.Patients admitted with sepsis and septic shock as defined by treating physician.
1.Patients not in sepsis and septic shock.
2.Patients in shock other than septic shock.
3.Patients presented as symptoms or diagnosis of Tropical Fever (Fever with thrombocytopenia).
4.Patients presenting with SIRS but not sepsis like pancreatitis, Heat stroke, Neoplasia, chemical aspiration, Trauma.
5.Patients with disease like splenomegaly, ITP or drugs induced thrombocytopenia.
6.Patients having malignancies or autoimmune diseases or bone marrow suppression.
7.Patients not willing to give consent for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation of PLR with APACHE 2 in sepsis with septic shock.Timepoint: 24 hours
- Secondary Outcome Measures
Name Time Method To evaluate prognostic role of PLR in 28 day mortality outcome in sepsis with septic shock.Timepoint: 28 days